Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HEPS | SE |
|---|---|---|
| Price | $2.66 | $93.15 |
| Change today | ▲ 0.19% | ▼ 1.60% |
| Market cap | $1.14B | $57.05B |
| Return, 3 months | -10.3% | -14.6% |
| Return, year to date | +7.1% | -27.0% |
| Return, 1 year | -0.9% | -51.7% |
| P/E (TTM) | -6.6 | 36.0 |
| P/B | -94.8 | 4.4 |
| P/E percentile vs own 5y | 62nd | 54th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +3.1% | +48.1% |
| Net profit growth (YoY) | -97.6% | +10.6% |
| Gross margin | 36.2% | 44.3% |
| Operating margin | -2.2% | 8.2% |
| Net margin | -8.0% | 5.9% |
| Return on equity | -636.5% | 14.5% |
| Analyst target vs. price | – | +66.4% |
| Analyst buy share | – | 89% |
| RSI (14) | 55 | 31 |
| 30-day volatility | 50.0% | 30.1% |
| Max drawdown, 1 year | -28.3% | -59.4% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
